Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Enasidenib Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Enasidenib Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Enasidenib Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Enasidenib Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Celgene Corporation
  • ...

By the Product Type, the market is primarily segmented into:

  • 50mg
  • 100mg

By Applications, the market is segmented into:

  • Hospital
  • Pharmacy

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Enasidenib Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Enasidenib Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Enasidenib Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Enasidenib Market

The Enasidenib Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Enasidenib Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Enasidenib Market Overview
1.1 Enasidenib Product Overview
1.2 Enasidenib Market Segment by Type
1.2.1 50mg
1.2.2 100mg
1.3 Global Enasidenib Market Size by Type
1.3.1 Global Enasidenib Sales and Growth by Type
1.3.2 Global Enasidenib Sales and Market Share by Type
1.3.3 Global Enasidenib Revenue and Market Share by Type
1.3.4 Global Enasidenib Price by Type
1.4 North America Enasidenib by Type
1.5 Europe Enasidenib by Type
1.6 South America Enasidenib by Type
1.7 Middle East and Africa Enasidenib by Type

2 Global Enasidenib Market Competition by Company
2.1 Global Enasidenib Sales and Market Share by Company (2014-2019)
2.2 Global Enasidenib Revenue and Share by Company (2014-2019)
2.3 Global Enasidenib Price by Company (2014-2019)
2.4 Global Top Players Enasidenib Manufacturing Base Distribution, Sales Area, Product Types
2.5 Enasidenib Market Competitive Situation and Trends
2.5.1 Enasidenib Market Concentration Rate
2.5.2 Global Enasidenib Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion

3 Enasidenib Company Profiles and Sales Data
3.1 Celgene Corporation
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Enasidenib Product Category, Application and Specification
3.1.3 Celgene Corporation Enasidenib Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
...

4 Enasidenib Market Status and Outlook by Regions
4.1 Global Enasidenib Market Status and Outlook by Regions
4.1.1 Global Enasidenib Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Enasidenib Sales and Revenue by Regions
4.2.1 Global Enasidenib Sales Market Share by Regions (2014-2019)
4.2.2 Global Enasidenib Revenue Market Share by Regions (2014-2019)
4.2.3 Global Enasidenib Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Enasidenib Sales, Revenue, Price and Gross Margin
4.3.1 North America Enasidenib Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Enasidenib Sales, Revenue, Price and Gross Margin
4.4.1 Europe Enasidenib Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Enasidenib Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Enasidenib Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Enasidenib Sales, Revenue, Price and Gross Margin
4.6.1 South America Enasidenib Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Enasidenib Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Enasidenib Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa

5 Enasidenib Application
5.1 Enasidenib Segment by Application
5.1.1 Hospital
5.1.2 Pharmacy
5.2 Global Enasidenib Product Segment by Application
5.2.1 Global Enasidenib Sales by Application
5.2.2 Global Enasidenib Sales and Market Share by Application (2014-2019)
5.3 North America Enasidenib by Application
5.4 Europe Enasidenib by Application
5.5 Asia-Pacific Enasidenib by Application
5.6 South America Enasidenib by Application
5.7 Middle East and Africa Enasidenib by Application

6 Global Enasidenib Market Forecast
6.1 Global Enasidenib Sales, Revenue Forecast (2019-2025)
6.1.1 Global Enasidenib Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Enasidenib Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Enasidenib Forecast by Regions
6.2.1 North America Enasidenib Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Enasidenib Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Enasidenib Sales and Revenue Forecast (2019-2025)
6.2.4 South America Enasidenib Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Enasidenib Sales and Revenue Forecast (2019-2025)
6.3 Enasidenib Forecast by Type
6.3.1 Global Enasidenib Sales and Revenue Forecast by Type (2019-2025)
6.3.2 50mg Growth Forecast
6.3.3 100mg Growth Forecast
6.4 Enasidenib Forecast by Application
6.4.1 Global Enasidenib Sales Forecast by Application (2019-2025)
6.4.2 Global Enasidenib Forecast in Hospital
6.4.3 Global Enasidenib Forecast in Pharmacy

7 Enasidenib Upstream Raw Materials
7.1 Enasidenib Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Enasidenib Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Table
List of Tables and Figures

Figure Enasidenib Product Picture
Figure Global Enasidenib Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Enasidenib Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of 50mg
Table Major Players of 50mg
Figure Global 50mg Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of 100mg
Table Major Players of 100mg
Figure Global 100mg Sales (K Units) and Growth Rate (2014-2019)
Table Global Enasidenib Sales (K Units) and Growth Rate Comparison by Type (K Units)
Table Global Enasidenib Sales (K Units) by Type (2014-2019) (K Units)
Table Global Enasidenib Sales Share by Type (2014-2019)
Figure Global Enasidenib Sales Market Share by Type (2014-2019)
Figure Global Enasidenib Sales Market Share by Type in 2018
Table Global Enasidenib Revenue (Million USD) by Type (2014-2019)
Table Global Enasidenib Revenue Share by Type (2014-2019)
Figure Global Enasidenib Revenue Share by Type (2014-2019)
Figure Global Enasidenib Revenue Market Share by Type in 2018
Table Global Enasidenib Price (USD/Unit) by Type (2014-2019)
Table North America Enasidenib Sales (USD/Unit) by Type (2014-2019)
Figure North America Enasidenib Sales Market Share by Type in 2018
Table Europe Enasidenib Sales (USD/Unit) by Type (2014-2019)
Figure Europe Enasidenib Sales Market Share by Type in 2018
Table Asia-Pacific Enasidenib Sales (USD/Unit) by Type (2014-2019)
Figure Asia-Pacific Enasidenib Sales Market Share by Type in 2018
Table South America Enasidenib Sales (USD/Unit) by Type (2014-2019)
Figure South America Enasidenib Sales Market Share by Type in 2018
Table Middle East and Africa Enasidenib Sales (USD/Unit) by Type (2014-2019)
Figure Middle East and Africa Enasidenib Sales Market Share by Type in 2018
Table Global Enasidenib Sales (K Units) by Company (2014-2019)
Table Global Enasidenib Sales Share by Company (2014-2019)
Figure Global Enasidenib Sales Share by Company in 2018
Table Global Enasidenib Revenue (Million US$) by Company (2014-2019)
Table Global Enasidenib Revenue Share by Company (2014-2019)
Figure Global Enasidenib Revenue Share by Company in 2018
Table Global Market Enasidenib Average Price (USD/Unit) by Company (2014-2019)
Table Global Enasidenib Top Company Manufacturing Base Distribution and Sales Area
Table Global Enasidenib Top Manufacturers Product Category
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Figure Global Enasidenib Market Share of Top 5 Company
Figure Global Enasidenib Market Share of Top 10 Company
Table Mergers & Acquisitions, Expansion Plans
Table Celgene Corporation Basic Information List
Table Celgene Corporation Enasidenib Product Category, Application and Specification
Table Celgene Corporation Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Celgene Corporation Description and Business Overview
Table Global Enasidenib Market Size Comparison by Regions (2014-2025) (K Units) & (Million US$)
Figure North America Enasidenib Revenue (Million USD) and Growth Rate (2014-2025)
Figure Asia-Pacific Enasidenib Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Enasidenib Revenue (Million USD) and Growth Rate (2014-2025)
Figure South America Enasidenib Revenue (Million USD) and Growth Rate (2014-2025)
Figure Middle East and Africa Enasidenib Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Enasidenib Sales (K Units) by Regions (2014-2019)
Table Global Enasidenib Sales Market Share by Regions (2014-2019)
Figure Global Enasidenib Sales Market Share by Regions (2014-2019)
Figure 2018 Global Enasidenib Sales Market Share by Regions
Table Global Enasidenib Revenue (Million USD) by Regions (2014-2019)
Table Global Enasidenib Revenue Market Share by Regions (2014-2019)
Figure Global Enasidenib Revenue Market Share by Regions (2014-2019)
Figure 2018 Global Enasidenib Revenue Market Share by Regions
Table Global Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Enasidenib Sales Growth Rate
Table North America Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure United States Enasidenib Sales (K Units)(2014-2019)
Figure United States Enasidenib Revenue (Million USD)(2014-2019)
Figure Canada Enasidenib Sales (K Units)(2014-2019)
Figure Canada Enasidenib Revenue (Million USD)(2014-2019)
Figure Mexico Enasidenib Sales (K Units)(2014-2019)
Figure Mexico Enasidenib Revenue (Million USD)(2014-2019)
Figure Europe Enasidenib Sales Growth Rate
Table Europe Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Germany Enasidenib Sales (K Units)(2014-2019)
Figure Germany Enasidenib Revenue (Million USD)(2014-2019)
Figure France Enasidenib Sales (K Units)(2014-2019)
Figure France Enasidenib Revenue (Million USD)(2014-2019)
Figure UK Enasidenib Sales (K Units)(2014-2019)
Figure UK Enasidenib Revenue (Million USD)(2014-2019)
Figure Italy Enasidenib Sales (K Units)(2014-2019)
Figure Italy Enasidenib Revenue (Million USD)(2014-2019)
Figure Russia Enasidenib Sales (K Units)(2014-2019)
Figure Russia Enasidenib Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Enasidenib Sales Growth Rate
Table Asia-Pacific Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Enasidenib Sales (K Units)(2014-2019)
Figure China Enasidenib Revenue (Million USD)(2014-2019)
Figure Japan Enasidenib Sales (K Units)(2014-2019)
Figure Japan Enasidenib Revenue (Million USD)(2014-2019)
Figure South Korea Enasidenib Sales (K Units)(2014-2019)
Figure South Korea Enasidenib Revenue (Million USD)(2014-2019)
Figure India Enasidenib Sales (K Units)(2014-2019)
Figure India Enasidenib Revenue (Million USD)(2014-2019)
Figure Australia Enasidenib Sales (K Units)(2014-2019)
Figure Australia Enasidenib Revenue (Million USD)(2014-2019)
Figure Indonesia Enasidenib Sales (K Units)(2014-2019)
Figure Indonesia Enasidenib Revenue (Million USD)(2014-2019)
Figure Thailand Enasidenib Sales (K Units)(2014-2019)
Figure Thailand Enasidenib Revenue (Million USD)(2014-2019)
Figure Malaysia Enasidenib Sales (K Units)(2014-2019)
Figure Malaysia Enasidenib Revenue (Million USD)(2014-2019)
Figure Philippines Enasidenib Sales (K Units)(2014-2019)
Figure Philippines Enasidenib Revenue (Million USD)(2014-2019)
Figure Vietnam Enasidenib Sales (K Units)(2014-2019)
Figure Vietnam Enasidenib Revenue (Million USD)(2014-2019)
Figure South America Enasidenib Sales Growth Rate
Table South America Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Brazil Enasidenib Revenue (Million USD)(2014-2019)
Figure Brazil Enasidenib Sales (K Units)(2014-2019)
Figure Middle East and Africa Enasidenib Sales Growth Rate
Table Middle East and Africa Enasidenib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Turkey Enasidenib Sales (K Units)(2014-2019)
Figure Turkey Enasidenib Revenue (Million USD)(2014-2019)
Figure GCC Countries Enasidenib Sales (K Units)(2014-2019)
Figure GCC Countries Enasidenib Revenue (Million USD)(2014-2019)
Figure Egypt Enasidenib Sales (K Units)(2014-2019)
Figure Egypt Enasidenib Revenue (Million USD)(2014-2019)
Figure South Africa Enasidenib Sales (K Units)(2014-2019)
Figure South Africa Enasidenib Revenue (Million USD)(2014-2019)
Figure Hospital Examples
Figure Pharmacy Examples
Table Global Enasidenib Sales (K Units) Comparison by Application (2014-2025)
Table Global Enasidenib Sales (K Units) by Application (2014-2019)
Table Global Enasidenib Sales Share by Application (2014-2019)
Figure Global Enasidenib Sales Market Share by Application (2014-2019)
Figure Global Enasidenib Sales Market Share by Application in 2018
Figure Global Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Enasidenib Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Enasidenib Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Enasidenib Sales Market Share Forecast by Regions (2019-2025)
Figure North America Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Europe Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure China Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Japan Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure South Korea Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Korea Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure India Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Australia Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Australia Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Indonesia Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Indonesia Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure South America Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South America Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Turkey Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Turkey Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure GCC Countries Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure GCC Countries Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure Egypt Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Egypt Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Figure South Africa Enasidenib Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Africa Enasidenib Revenue and Growth Rate Forecast (2019-2025)
Table Global Enasidenib Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Enasidenib Sales Market Share Forecast by Type (2019-2025)
Table Global Enasidenib Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Enasidenib Revenue Market Share Forecast by Type (2019-2025)
Figure 50mg Sales Growth Forecast
Figure 100mg Sales Growth Forecast
Table Global Enasidenib Sales (K Units) Forecast by Application (2019-2025)
Figure Global Enasidenib Sales Forecast by Application (2019-2025)
Figure Global Enasidenib Sales (K Units) Forecast in Hospital
Figure Global Enasidenib Sales (K Units) Forecast in Pharmacy
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Enasidenib Manufacturing Cost Structure
Figure Enasidenib Industrial Chain Analysis
Table Distributors List
Table Enasidenib Downstream Customers
Table Research Programs/Design for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us